Your browser is no longer supported. Please, upgrade your browser.
SVA Sinovac Biotech Ltd. daily Stock Chart
SVA [NASD]
Sinovac Biotech Ltd.
Index- P/E24.15 EPS (ttm)0.33 Insider Own11.40% Shs Outstand53.59M Perf Week-3.80%
Market Cap420.68M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float40.85M Perf Month-9.56%
Income18.50M PEG2.01 EPS next Q- Inst Own31.60% Short Float1.71% Perf Quarter-2.36%
Sales127.00M P/S3.31 EPS this Y-321.60% Inst Trans0.01% Short Ratio11.24 Perf Half Y11.03%
Book/sh2.29 P/B3.43 EPS next Y- ROA8.80% Target Price6.00 Perf Year40.43%
Cash/sh1.03 P/C7.65 EPS next 5Y12.00% ROE15.70% 52W Range4.60 - 8.75 Perf YTD-0.38%
Dividend- P/FCF- EPS past 5Y-27.20% ROI-1.40% 52W High-10.29% Beta0.06
Dividend %- Quick Ratio1.90 Sales past 5Y5.00% Gross Margin82.90% 52W Low70.65% ATR0.31
Employees724 Current Ratio2.10 Sales Q/Q508.20% Oper. Margin23.00% RSI (14)42.18 Volatility8.18% 3.92%
OptionableYes Debt/Eq0.28 EPS Q/Q- Profit Margin14.60% Rel Volume0.40 Prev Close7.88
ShortableYes LT Debt/Eq0.09 EarningsApr 30 BMO Payout0.00% Avg Volume62.30K Price7.85
Recom3.00 SMA20-4.84% SMA50-4.92% SMA2003.88% Volume24,683 Change-0.38%
Aug-15-14Reiterated Aegis Capital Buy $7 → $10
Aug-15-13Upgrade Aegis Capital Hold → Buy $7
Dec-12-12Initiated Aegis Capital Hold $2.50
Jan-07-11Reiterated Brean Murray Buy $5.50 → $4.80
Jan-04-11Downgrade WBB Securities Buy → Speculative Buy $7.50 → $7.50
Nov-11-10Upgrade Brean Murray Hold → Buy $5.50
Apr-20-10Initiated WBB Securities Buy $7.50
Apr-06-10Downgrade Brean Murray Buy → Hold
Feb-13-09Upgrade SMH Capital Neutral → Accumulate $31 → $27
Jul-09-08Initiated Brean Murray Buy $5
Apr-19-18 09:10AM  Sinovac Announces Preliminary Results of Phase III Trial on sIPV PR Newswire +6.78%
Apr-18-18 04:30PM  Sinovac Sets the Record Straight Regarding False Statements by Shandong Sinobioway Biomedicine Co., Ltd. PR Newswire -9.34%
Apr-16-18 02:40PM  10 Bulletproof Blue-Chip Growth Stocks to Invest In InvestorPlace
Apr-06-18 02:23PM  10 Healthcare Stocks to Stave Off the Market Flu InvestorPlace
Mar-30-18 07:59PM  Why Sinovac Biotech Ltds (NASDAQ:SVA) ROE Of 18.01% Does Not Tell The Whole Story Simply Wall St.
Mar-27-18 07:40AM  Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction PR Newswire
Mar-15-18 06:24AM  Sinovac Sets the Record Straight Regarding False Statements by Unauthorized Third Parties PR Newswire
Mar-14-18 04:14PM  What Does Sinovac Biotech Ltds (NASDAQ:SVA) Ownership Structure Look Like? Simply Wall St.
09:23AM  Sinovac Newly-Elected Board of Directors' Response to the Announcement of the Purported Re-Election of All Directors at the February 6, 2018 Annual General Meeting PR Newswire
Mar-06-18 04:01PM  Sinovac Amends Shareholder Rights Plan PR Newswire
Mar-05-18 08:35PM  Sinovac Announces Enhancement of Corporate Governance and Management of China Operating Entity PR Newswire
04:31PM  Sinovac Announces Re-Election of All Directors at Annual General Meeting PR Newswire
Feb-07-18 08:50AM  Sinovac Provides Update on Going Private Transaction PR Newswire
08:48AM  Sinovac Holds 2017 Annual General Meeting of Shareholders PR Newswire
Jan-05-18 08:30AM  What You Must Know About Sinovac Biotech Ltds (NASDAQ:SVA) Risks Simply Wall St.
Dec-29-17 06:00AM  Sinovac Schedules 2017 Annual Meeting of Shareholders PR Newswire
Dec-28-17 09:15AM  Should You Be Tempted To Buy Sinovac Biotech Ltd (NASDAQ:SVA) Because Of Its PE Ratio? Simply Wall St.
Dec-22-17 12:05PM  Sinovac Biotech Receives Positive Decision on its Hepatitis A Vaccine from World Health Organization PR Newswire
Dec-21-17 07:40AM  Wired News Onconova Signs License and Collaborative Development Agreement with HanX Biopharma for ON 123300 ACCESSWIRE
Dec-20-17 07:30AM  Blog Exposure - BeiGene Announced Initiation of Pivotal Trial of PARP Inhibitor Pamiparib in Chinese Patients with Ovarian Cancer ACCESSWIRE
Dec-01-17 06:00AM  Sinovac Reports Unaudited First Half of 2017 Financial Results PR Newswire
06:00AM  Sinovac Biotech Cures Nasdaq Filing Deficiency PR Newswire
Nov-30-17 06:00AM  Sinovac Biotech Announces Update on Nasdaq Matters PR Newswire
Nov-22-17 05:01PM  Sinovac posts 4Q profit Associated Press
04:30PM  Sinovac Files 2016 Annual Report on Form 20-F and Reports Unaudited Fourth Quarter 2016 Financial Results PR Newswire
Nov-10-17 06:55PM  Is Sinovac Biotech Ltds (SVA) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Nov-08-17 04:20PM  Sinovac Biotech Announces Request Hearing before Nasdaq Hearings Panel PR Newswire
Nov-03-17 04:20PM  Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq PR Newswire
Oct-12-17 08:00AM  Sinovac Completed its 23-Valent Pneumococcal Polysaccharide Vaccine Phase III Clinical Trial and Filed the New Drug Application to CFDA PR Newswire
Sep-25-17 06:00AM  Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for Varicella Vaccine Candidate Against Chickenpox PR Newswire
Sep-11-17 11:45AM  Should You Be Concerned About Sinovac Biotech Ltds (SVA) Risks? Simply Wall St.
Sep-08-17 11:09AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : September 8, 2017 Capital Cube
Sep-01-17 01:00PM  DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA ACCESSWIRE
10:06AM  FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017 ACCESSWIRE
Aug-31-17 05:41PM  DEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
02:05PM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017 ACCESSWIRE
10:30AM  DEADLINE TOMORROW: The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA) ACCESSWIRE
Aug-30-17 03:20PM  DEADLINE FRIDAY: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm GlobeNewswire
02:12PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA ACCESSWIRE
10:30AM  September 1st Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sinovac Biotech Ltd. Business Wire
10:05AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017 ACCESSWIRE
Aug-29-17 03:02PM  SVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017 ACCESSWIRE
Aug-25-17 11:55PM  ONE WEEK DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm GlobeNewswire
10:47AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA ACCESSWIRE
Aug-24-17 06:05PM  8-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
01:59PM  SVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017 ACCESSWIRE
Aug-23-17 03:35PM  SEPTEMBER 1 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:05AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA ACCESSWIRE
Aug-22-17 05:33PM  DEADLINE REMINDER: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
04:32PM  IMMINENT SINOVAC LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Sinovac Biotech, Ltd. To Contact The Firm ACCESSWIRE
01:49PM  DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Sinovac Biotech Ltd. (Nasdaq: SVA) To Contact The Firm GlobeNewswire
12:12PM  SVA EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017 ACCESSWIRE
Aug-21-17 08:00PM  SINOVAC LOSS NOTICE: Rosen Law Firm Reminds Sinovac Biotech Ltd. Investors of Important Deadline in First Filed Class Action - SVA PR Newswire
01:02PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA ACCESSWIRE
Aug-18-17 11:25PM  DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
12:04PM  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA) ACCESSWIRE
Aug-17-17 07:47PM  SVA INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
11:05AM  SVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017 ACCESSWIRE
10:03AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) and Lead Plaintiff Deadline - September 1, 2017 ACCESSWIRE
Aug-16-17 02:07PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA ACCESSWIRE
Aug-15-17 02:11PM  UPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
Aug-14-17 04:08PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA ACCESSWIRE
02:26PM  UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
06:00AM  Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F PR Newswire
Aug-11-17 10:19AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SV ACCESSWIRE
10:03AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) and Lead Plaintiff Deadline - September 1, 2017 ACCESSWIRE
Aug-10-17 01:07PM  APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
10:27AM  The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA) GlobeNewswire
Aug-09-17 12:53PM  EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
12:00PM  SVA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017 GlobeNewswire
Aug-08-17 07:16PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Sinovac Biotech Ltd. - SVA PR Newswire
04:18PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
11:18AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 SVA GlobeNewswire
10:02AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) and Lead Plaintiff Deadline - September 1, 2017 ACCESSWIRE
Aug-07-17 04:57PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
12:29PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA ACCESSWIRE
Aug-04-17 11:59PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
Aug-03-17 05:22PM  SVA EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017 ACCESSWIRE
03:05PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
10:13AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017 ACCESSWIRE
Aug-02-17 09:43AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA ACCESSWIRE
Aug-01-17 04:05PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
11:20AM  The Klein Law Firm Notifies Investors of Commencement of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA) ACCESSWIRE
Jul-31-17 04:00PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
10:19AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA ACCESSWIRE
Jul-28-17 11:57PM  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
12:27PM  SVA INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017 ACCESSWIRE
09:00AM  SINOVAC NOTICE: Rosen Law Firm Reminds Sinovac Biotech Ltd. Investors of Important Deadline in First Filed Class Action - SVA GlobeNewswire
Jul-27-17 12:30PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm GlobeNewswire
11:15AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA ACCESSWIRE
Jul-26-17 05:06PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm GlobeNewswire
04:59PM  SINOVAC LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Sinovac Biotech, Ltd. To Contact The Firm GlobeNewswire
11:40AM  The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA) GlobeNewswire
10:54AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017 Accesswire
Jul-25-17 12:50PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm Accesswire
11:52AM  SVA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017 GlobeNewswire
Jul-24-17 05:41PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm Accesswire
10:07AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sinovac Biotech Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 SVA GlobeNewswire
Jul-21-17 11:56PM  EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm Accesswire
12:54PM  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 Business Wire
Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against human infectious diseases in the People's Republic of China. The company's product portfolio includes vaccines against enterovirus71 (EV710), hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps, as well as hand, foot, and mouth diseases. Its marketed products include Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a split viron influenza vaccine; Panflu, a vaccine against the H5N1 influenza virus; Panflu.1, a vaccine against the influenza A H1N1 virus; mumps vaccine; and split viron pandemic influenza vaccine. The company also completed phase III clinical trials for EV71, varicella, and pneumococcal polysaccharide vaccines. In addition, it has completed pre-clinical studies for sabin inactivated polio; and focuses on commencing clinical trials for pneumococcal conjugate, Quadrivalent influenza, and rubella vaccines. The company has a collaboration agreement with GlaxoSmithKline Biologicals SA to develop combination vaccines containing measles for the China market; Tianjin CanSino Biotechnology Inc. to develop a pneumococcal conjugate vaccine; and a license agreement with Medimmune, LLC to use patented reverse genetics technology pertaining to H5N1 influenza virus strain production for vaccines. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the People's Republic of China.